ETEST COLISTIN CO256 WW 의 안전성 경고

Department of Health에 따르면, 해당 안전성 경고 는 Hong Kong 에서 BioMerieux 에 의해 제조된 제품과 관련되어 있습니다.

이것은 무엇인가요?

안전성 경고는 의료기기 제품과 관련된 중요한 정보와 권고사항을 담고 있습니다. 물론 안전성 경고가 배포되었다고 해서 해당 제품이 무조건 안전하지 않은 제품이라는 것은 아닙니다. 보건의료업계 종사자와 의료기기 사용자들에게 배포되는 안전성 경고에는 회수(recall)도 포함될 수 있습니다. 제조사가 안전성 경고를 작성하기도 하지만, 보건당국에서 작성하는 경우도 있습니다.

데이터에 대해 더 자세히 알아보기 여기
  • 사례 유형
    Safety alert
  • 날짜
    2016-12-16
  • 사례 출판 날짜
    2016-12-16
  • 사례 국가
  • 사례 출처
    DH
  • 사례 출처 URL
  • 비고 / 경고
    Hong Kong data is current through September 2018. All of the data comes from the Department of Health (Hong Kong), except for the categories Manufacturer Parent Company and Product Classification.
    The Parent Company and the Product Classification were added by ICIJ.
    The parent company information is based on 2017 public records. The device classification information comes from FDA’s Product Classification by Review Panel, based on matches of data from the U.S. and Hong Kong.
  • 데이터 추가 비고
    Medical Device Safety Alert
  • 원인
    Medical device safety alert: biomerieux etest colistin co256 ww medical device manufacturer, biomerieux, has issued a field safety notice (fsn) concerning its etest colistin co256 ww. the affected product reference numbers are 537300 and 537308. based on the first results of investigations due to a potential underestimation of the minimum inhibitory concentrations (mic) values for enterobacteriaceae and acinetobacter, a fsn stating that etest colistin co256 ww can only be used for diagnostic purposes with mh-e (mueller hinton-e agar from the manufacturer’s ref.: 413822-413823-413824-413825) agar for enterobacteriaceae strains was issued on 25 july 2016. since then, further investigations were performed and the potential hazards have been identified: for salmonella strains that have not the mcr-1 gene, in 20% of the cases, there is a potential of very major error (vme): resistant gives susceptible (r → s) on etest colistin co256 compared to the broth micro-dilution (bmd) method. according to the manufacturer, there is no risk of vme for salmonella strains that have the mcr1 gene in case of epidemiological use. for p.Aeruginosa strains, there is a potential of vme resistant gives susceptible (r → s) for p.Aeruginosa strains on etest colistin co256 compared to broth-micro dilution (bmd) method. this potential issue was already corrected by the past fsn. there is a potential under-estimation of the mic values for susceptible enterobacteriaceae strains. for diagnostic purposes, users can continue to use the affected product, only if it is used with mh-e agar (mueller hinton-e agar from the manufacturer’s ref.: 413822-413823-413824-413825) for enterobacteriaceae (except for salmonella strains) with the following recommendations: categorization (susceptible or resistant) results need to be reported based on the eucast (s ≤2 mg/l et >2 mg/l r) critical concentrations. due to the under-estimation of the mic for enterobacteriaceae susceptible strains, to verify the mic of susceptible strains as needed with the bmd method of reference before reporting results. if users do not use mueller hinton-e agar, or if users test other strains, the manufacturer recommends users to restrict its use to epidemiological surveys. in case of epidemiological use with other agars than mh-e supplied by the manufacturer, the manufacturer recommends users to validate the agar before use. among tests previously performed, the manufacturer is asking users to identify any possible false susceptible results, analyze the related risks and determine appropriate actions if relevant. according to the local supplier, the affected products are distributed in hong kong. if you are in possession of the products, please contact your supplier for necessary actions. posted on 16 december 2016.

Device

  • 모델명 / 제조번호(시리얼번호)
  • 제품 설명
    Medical Device Safety Alert: BioMerieux ETEST COLISTIN CO256 WW
  • Manufacturer

Manufacturer